Sixera Pharma logo

Sixera Pharma jobs and careers

Sweden

About Sixera Pharma

We are developing a topical skin treatment for the serious and rare skin disease Netherton syndrome. A clinical phase I/II trial has started - this will demonstrate safety and efficacy of the treatment in patients with Netherton syndrome.

Founded in 2017 by Maarten de Château.

Founded
2017
Employees
1 to 10
Headquarters
Sweden